Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease hyperthermia
Comorbidity C0376545|hematological malignancies
Sentences 16
PubMedID- 22111760 Bacteria and fungi are the major etiological agents of chemotherapy induced febrile neutropenia in patients with hematological malignancies [1,2].
PubMedID- 24164924 The identification of risk factors and outcomes of vre bsi is necessary for establishing strategies for managing neutropenic fever in patients with hematological malignancies.
PubMedID- 26124158 Adequacy of high-dose cefepime regimen in febrile neutropenic patients with hematological malignancies.
PubMedID- 24642872 For example, fever in patients with hematological malignancies may depend on infection, lysis of malignant cells, and/or chemotherapy-induced mucosal damage.
PubMedID- 20882524 Micafungin is safe and effective for the empirical antifungal therapy of febrile neutropenia in patients with hematological malignancies.
PubMedID- 23372683 Antibiotic rotation for febrile neutropenic patients with hematological malignancies: clinical significance of antibiotic heterogeneity.
PubMedID- 23668467 Antimicrobial agent prescription patterns for chemotherapy-induced febrile neutropenia in patients with hematological malignancies at sultan qaboos university hospital, oman.
PubMedID- 22978686 Moxifloxacin is more effective than tosufloxacin in reducing chemotherapy-induced febrile neutropenia in patients with hematological malignancies.
PubMedID- 26295293 This study aimed to investigate fungal agents in febrile neutropenic patients with hematological malignancies.
PubMedID- 25587291 Conclusion: micafungin has similar efficacy to caspofungin as empirical antifungal therapy in febrile neutropenic patients with hematological malignancies.
PubMedID- 25152113 Conclusion: itraconazole injection was an effective and safe agent in targeted and diagnostic- driven antifungal therapy for immunocompromised or neutropenic febrile patients with hematological malignancies.
PubMedID- 23317527 Randomized controlled trial comparing ciprofloxacin and cefepime in febrile neutropenic patients with hematological malignancies.
PubMedID- 20227988 Hema e-chart: italian registry for prospective analysis of epidemiology, management and outcome of febrile events in patients with hematological malignancies.
PubMedID- 20807030 We investigated mold colonization of air handling units (ahus) of heating, ventilating, and air conditioning (hvac) systems and its effects, including invasive pulmonary mycoses and febrile neutropenia, in patients with hematological malignancies.
PubMedID- 20471883 Cefepime-resistant gram-negative bacteremia in febrile neutropenic patients with hematological malignancies.
PubMedID- 20662227 [optimal administration of antimicrobial agents for febrile neutropenia in patients with hematological malignancies].

Page: 1